Stem Cell Therapy Market : Study on Key Players | Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, BioTime Inc., Mesoblast Ltd., Seneca Biopharma Inc., Opexa Therapeutics Inc., Pluristem Therapeutics Inc., STEMCELL Technologies Inc., ThermoGenesi

The global stem cell therapy market is projected to grow at a CAGR of over 8% during the forecast period. The market growth is attributed to the rising prevalence of rare genetic illnesses. Rare disorders such as thalassemia, cystic fibrosis, and others affect millions of individuals each year. According to World Health Organization (WHO), chronic diseases cause 41 million mortalities every year, equivalent to 71% of all mortalities globally. Furthermore, developments in stem cell therapies that improve the pace of recovery in cancer patients are projected to increase their demand. Significant government funding and initiatives for regenerative medicine research and development activities in the developed region will further drive the market growth.

Market Segmentation

The global stem cell therapy market has been analyzed on the basis of product, therapy type, technology, therapeutic application, end use, and region. Based on the product, the market is segmented into adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic-like stem cells. Among these, ASCs segment is estimated to hold a prominent share in the market. Based on therapy type, the market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. Among these, allogeneic stem cell therapy is estimated to hold a prominent share in the market.

Download Free PDF Sample of Stem Cell Therapy Market report @ https://www.themarketinsights.com/request-sample/265119

Based on technology, the market is segmented into cell acquisition, cell production, cryopreservation, and expansion and sub-culture. Among these, cell production is estimated to grow at a significant rate during the forecast period. Based on therapeutic application, the market is segmented into oncology, orthopedic, neurology, cardiovascular & myocardial infraction, hematology, and others. Among these, oncology segment is estimated to hold a prominent share while neurology is projected to exhibit remarkable growth during the forecast period. Further, on the basis of end use, the market covers the analysis of hospitals and research organization.

Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa.
Market Structure and Competition Landscape
The growth of the global stem cell therapy market is characterized by the presence of players operating in the market. Some of the players operating in the market include Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, BioTime Inc., Mesoblast Ltd., Seneca Biopharma Inc., Opexa Therapeutics Inc., Pluristem Therapeutics Inc., STEMCELL Technologies Inc., ThermoGenesis Holdings Inc., Astellas Pharma Inc., and Caladrius Biosciences Inc. among others. To grow their business, companies use techniques including new product launches, mergers and acquisitions, partnership and collaborations, etc.

Request Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265119

In March 2021, NOVADIP Biosciences S.A. received FDA approval for its Investigational New Drug (IND) application for its autologous cell treatment product NVD-003. This strategy is expected to boost their market position by improving their product offerings and expanding their consumer base.

In April 2020, Seneca Biopharma Inc. announced the completion of its new cell manufacturing facility in Suzhou, China. The company will manufacture NSI-566 in this new facility, which is the company's leading stem cell therapy.

To Check Discount @ https://www.themarketinsights.com/check-discount/265119

Table of Content

Chapter One: Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation

Chapter Two: Assumptions and Acronyms

Chapter Three: Executive Summary
3.1. Global Market in2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends

Chapter Four: Research Methodology

Chapter Five: Analysis of COVID-19 Impact and Road Ahead

Chapter Six: Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Global Stem Cell Therapy Professionals in the select countries
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, healthcare expenditures, industry players expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter's Five Forces Analysis

Chapter Seven: Government Laws and Industry Regulations

Chapter Eight: Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities

Chapter Nine: Global Stem Cell Therapy Market: Key Investment Analysis

Contact us

Jessica Joyal
Contact No. +16146022897
Email: sales@themarketinsights.com
Website: www.themarketinsights.com

About us

Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.